Acg Universal Capsules Profile
Key Indicators
- Authorised Capital ₹ 115.00 Cr
as on 09-07-2024
- Paid Up Capital ₹ 115.00 Cr
as on 09-07-2024
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 462.00 Cr
as on 09-07-2024
About Acg Universal Capsules
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 115.00 Cr and a paid-up capital of Rs 115.00 Cr.
The company currently has active open charges totaling ₹462.00 Cr.
The Key Managerial Personnel (KMP) at Acg Universal Capsules Private Limited India is Rashmi Mishra as COMPANY SECRETARY. Karan Singh and Selwyn Jonas serve as directors at the Company.
- CIN/LLPIN
U24230MH2021PTC364336
- Company No.
364336
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jul 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Acg Universal Capsules?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rashmi Mishra  | Company Secretary | 21-Mar-2024 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Selwyn Jonas | Director | 21-Jul-2021 | Current |
Karan Singh  | Director | 21-Jul-2021 | Current |
Financial Performance and Corporate Structure Insights of Acg Universal Capsules.
Acg Universal Capsules Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Acg Universal Capsules?
In 2022, Acg Universal Capsules had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Acg Associated Capsules Private LimitedActive 63 years 5 monthsKaran Singh and Selwyn Jonas are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 Sep 2022 | ₹462.00 Cr | Open |
How Many Employees Work at Acg Universal Capsules?
Acg Universal Capsules has a workforce of 94 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Acg Universal Capsules, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acg Universal Capsules's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
